Donald Owen, Ph.D.
Owen Biosciences, Inc
Dr. Donald Owen the founder of OBI and TPI a has been involved in various academic and corporate research for over 40 years. These research efforts have resulted in numerous scientific papers as well as over thirty patents or patents pending. Research interests include bioemulsion/ nanoemulsion technology, anti-aging/proliferative oligopeptides, anti-microbial lipopeptides, peptidic GH secretegogues and the use biotechnology for green bioactives.
Dr. Owen has seen several of these technologies and inventions move from the laboratory to the developmental and final product stage. In turn, various corporations have formed such as an organ preservation corporation (Organ Recovery Systems Inc.) and a personal healthcare company (OBI) to market the products which have evolved from these research efforts. TPI was established by Dr. Owen to develop and market therapeutic peptides for anti-aging, wound healing and the treatment of infectious diseases. Lipo-oligopeptides for cosmetic applications produced by TPI are now distributed by Symrise Inc,
The aging mechanisms of skin in particular and body in general are being elucidated because of major recent advances in DNA biotechnology. OBI and sister company TPI are taking advantage of these discoveries and those of its own scientists to develop novel new ingredients and topical delivery technologies for combating the aging process. The mission of OBI is to focus on the practical problems of producing unique bioactives including biotechnology based ingredients for age prevention and repair of human skin.
Post a Comment
Note: Only a member of this blog may post a comment.